Improvement in mitochondrial function underlies the effects of ANNAO tablets on attenuating cerebral ischemia-reperfusion injuries-Reference-Cited by-同舟云学术

Improvement in mitochondrial function underlies the effects of ANNAO tablets on attenuating cerebral ischemia-reperfusion injuries

Published:2020-01 Issue: Volume:246 Page:112212
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Zhang Yi,Cao Mingyue,Wu Youming,Wang Jun,Zheng Ji,Liu Nasi,Yang Nan,Liu Yanyong

Funder

Natural Science Foundation of China

foundation of Zhejiang Jolly Pharmaceutical Co., Ltd

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference38 articles.

1. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats;Chen;Stroke,2001

2. Chinese medicine injection qingkailing for treatment of acute ischemia stroke: a systematic review of randomized controlled trials;Cheng;Evid Based Complement Altern Med,2012

3. Neuroprotection by local intra-arterial infusion of erythropoietin after focal cerebral ischemia in rats;Dang;Neurol. Res.,2011

4. Functions and dysfunctions of mitochondrial dynamics;Detmer;Nat. Rev. Mol. Cell Biol.,2007

5. Stroke epidemiology in the developing world;Feigin;Lancet,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-pathway neuroprotective effects of a novel salidroside derivative SHPL-49 against acute cerebral ischemic injury;European Journal of Pharmacology;2023-06

2. Traditional Chinese medicine in treating ischemic stroke by modulating mitochondria: A comprehensive overview of experimental studies;Frontiers in Pharmacology;2023-03-22

3. Targeting the Neurovascular Unit: Therapeutic Potential of Traditional Chinese Medicine for the Treatment of Stroke;2023

4. Shumian Capsule Improves the Sleep Disorder and Mental Symptoms Through Melatonin Receptors in Sleep-Deprived Mice;Frontiers in Pharmacology;2022-07-08

5. Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection;Antioxidants;2022-01-20